Aceragen Inc reports results for the quarter ended in March - Earnings Summary

Aceragen

29/06/2023 23:08

* Aceragen Inc  ACGN.OQ  reported a quarterly adjusted loss
of
$1.45​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of $2.12 per
share.
    * Revenue was $2.47 million​; analysts expected zero. 
    * Aceragen Inc's reported EPS for the quarter was a loss of
$2.94​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Aceragen Inc shares had fallen by 34.1% this quarter and
lost 74.6% so far this year.
    * The company reported a quarterly loss of $21.87 million.
    * Wall Street's median 12-month price target for Aceragen
Inc is
$17.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data June
29 at 10:08 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -2.12          -1.45          Beat
                                  -2.94          
                                  1.02